Document is current
Any future updates will be listed below
-
Authors
Hofer, Thomas P. https://orcid.org/0000-0002-9713-3138
Nieto, Alexander E.
Käsmann, Lukas
Pelikan, Carolyn J.
Taugner, Julian
Mathur, Saloni
Eze, Chukwuka
Belka, Claus
Manapov, Farkhad
Noessner, Elfriede https://orcid.org/0000-0003-4709-9266
-
Funding
Funding for this research was provided by:
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
- License Information
-
More Information
Article History
Received: 21 June 2024
Accepted: 10 March 2025
First Online: 20 March 2025
Declarations
:
: The study was approved by the Human Ethics Committee of the Ludwig-Maximilians-University of Munich reference no. 17–632 and conducted in accordance with the Declaration of Helsinki. Patients were included into the study after informed consent.
: Not applicable.
: Lukas Kaesmann reports a relationship with AstraZeneca that includes: funding grants. Lukas Kaesmann reports a relationship with Amgen Europe GmbH that includes: speaking and lecture fees. Claus Belka reports a relationship with Brainlab AG that includes: funding grants. Claus Belka reports a relationship with Elekta that includes: funding grants. Claus Belka reports a relationship with ViewRay Inc that includes: consulting or advisory, funding grants, speaking and lecture fees, and travel reimbursement. Claus Belka reports a relationship with Bristol Myers Squibb Co that includes: consulting or advisory, speaking and lecture fees, and travel reimbursement. Claus Belka reports a relationship with Roche that includes: consulting or advisory, speaking and lecture fees, and travel reimbursement. Claus Belka reports a relationship with Merck & Co Inc that includes: consulting or advisory, speaking and lecture fees, and travel reimbursement. Claus Belka reports a relationship with AstraZeneca that includes: consulting or advisory, speaking and lecture fees, and travel reimbursement. Claus Belka reports a relationship with European SocieTy for Radiotherapy and Oncology that includes: board membership. Farkhad Manapov reports a relationship with AstraZeneca that includes: board membership, funding grants, and speaking and lecture fees. Farkhad Manapov reports a relationship with Novartis that includes: board membership and speaking and lecture fees. Farkhad Manapov reports a relationship with Roche that includes: speaking and lecture fees. Farkhad Manapov reports a relationship with Eli Lilly and Company that includes: speaking and lecture fees. Farkhad Manapov reports a relationship with Elekta that includes: speaking and lecture fees. Farkhad Manapov reports a relationship with Brainlab AG that includes: speaking and lecture fees.All other authors do not have any competing interests.
